Migraine clinical trials in Alabama
5 studies for Migraine are looking for participants at sites in Alabama.
Cities in Alabama
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Rehabilitation and Neurological Services /ID# 270782, Huntsville
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 22, 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- University of Alabama at Birmingham Children's of Alabama, Birmingham
Recruiting
Ages 10 to 17 · All sexes · Updated Sep 21, 2026 · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Rehabilitation & Neurological Services /ID# 229969, Huntsville
- The Center for Clinical Trials - Saraland /ID# 231546, Saraland
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Central Research Associates, LLC (CRA) dba Flourish Research, Birmingham
- AMR Mobile, Mobile
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 20, 2026 · NCT07645924A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- Flourish - Birmingham, Birmingham
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated May 19, 2026 · NCT06602479From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.